Agios Pharmaceuticals plans to share data from RISE UP with the Food and Drug Administration to support the approval of the sickle cell disease indication.
Healthy human red blood cells (RBCs) gradually degrade over their lifespan of ~120 days. However, sickle cells - RBCs from sickle cell disease (SCD) patients - degrade much faster within their ...
Hosted on MSN
Sickle Cell: I Still Have Crisis - Adekunle Gold
Nigerian singer, Adekunle Gold, has disclosed that he continues to experience sickle cell crisis, despite managing the condition since childhood. In a recent interview with Nandoleaks, the ...
Kyverna Therapeutics has reported deep, sustained improvements in autoimmune disease patients who received a single dose of its CAR T-cell therapy KYV-101. The data come from the phase 2 part of a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback